These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22713763)

  • 21. Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.
    Kim Y; Lillo AM; Steiniger SC; Liu Y; Ballatore C; Anichini A; Mortarini R; Kaufmann GF; Zhou B; Felding-Habermann B; Janda KD
    Biochemistry; 2006 Aug; 45(31):9434-44. PubMed ID: 16878978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Her-2 monoclonal antibody conjugated polymer fluorescent nanoparticles probe for ovarian cancer imaging.
    Hun X; Zhang Z; Tiao L
    Anal Chim Acta; 2008 Sep; 625(2):201-6. PubMed ID: 18724995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of paclitaxel (taxol), cisplatin, and the combination paclitaxel-cisplatin in ovarian cancer in vitro with the ATP cell viability assay.
    Untch M; Sevin BU; Perras JP; Angioli R; Untch A; Hightower RD; Koechli O; Averette HE
    Gynecol Oncol; 1994 Apr; 53(1):44-9. PubMed ID: 7909786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
    Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
    Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of paclitaxel-induced apoptosis in an ovarian cancer cell line and its paclitaxel-resistant clone.
    Sugimura M; Sagae S; Ishioka S; Nishioka Y; Tsukada K; Kudo R
    Oncology; 2004; 66(1):53-61. PubMed ID: 15031599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
    Kocbek P; Obermajer N; Cegnar M; Kos J; Kristl J
    J Control Release; 2007 Jul; 120(1-2):18-26. PubMed ID: 17509712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient inhibition of ovarian cancer by short hairpin RNA targeting claudin-3.
    Sun C; Yi T; Song X; Li S; Qi X; Chen X; Lin H; He X; Li Z; Wei Y; Zhao X
    Oncol Rep; 2011 Jul; 26(1):193-200. PubMed ID: 21519794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
    Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model.
    Devalapally H; Shenoy D; Little S; Langer R; Amiji M
    Cancer Chemother Pharmacol; 2007 Mar; 59(4):477-84. PubMed ID: 16862429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of GRP94 in breast cancer cells resistant to oxidative stress promotes high levels of cancer cell proliferation and migration: implications for tumor recurrence.
    Dejeans N; Glorieux C; Guenin S; Beck R; Sid B; Rousseau R; Bisig B; Delvenne P; Buc Calderon P; Verrax J
    Free Radic Biol Med; 2012 Mar; 52(6):993-1002. PubMed ID: 22245095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU; Kona S; Wadajkar AS; Desai F; Vadla A; Nguyen KT
    J Biomed Mater Res A; 2012 Aug; 100(8):1998-2005. PubMed ID: 22566409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sulfonates-PMMA nanoparticles conjugates: a versatile system for multimodal application.
    Monasterolo C; Ballestri M; Sotgiu G; Guerrini A; Dambruoso P; Sparnacci K; Laus M; De Cesare M; Pistone A; Beretta GL; Zunino F; Benfenati V; Varchi G
    Bioorg Med Chem; 2012 Nov; 20(22):6640-7. PubMed ID: 23043726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled glycosylation of therapeutic antibodies in plants.
    Tekoah Y; Ko K; Koprowski H; Harvey DJ; Wormald MR; Dwek RA; Rudd PM
    Arch Biochem Biophys; 2004 Jun; 426(2):266-78. PubMed ID: 15158677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential N-glycosylation of a monoclonal antibody expressed in tobacco leaves with and without endoplasmic reticulum retention signal apparently induces similar in vivo stability in mice.
    Triguero A; Cabrera G; Rodríguez M; Soto J; Zamora Y; Pérez M; Wormald MR; Cremata JA
    Plant Biotechnol J; 2011 Dec; 9(9):1120-30. PubMed ID: 21819534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma.
    Hong GY; Jeong YI; Lee SJ; Lee E; Oh JS; Lee HC
    Arch Pharm Res; 2011 Mar; 34(3):407-17. PubMed ID: 21547672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
    Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
    J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.